paroxetine has been researched along with lysergic acid diethylamide in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 10 (52.63) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karnovsky, ML; Polanski, M | 1 |
| Brewster, WK; Johnson, MP; Nichols, DE; Oberlender, R; Riggs, RM | 1 |
| Galzin, AM; Langer, SZ; Moret, C; Verzier, B | 1 |
| Bardgett, ME; Black, KJ; Csernansky, JG; Sheline, YI | 1 |
| Bakish, D; Chudzik, J; Hrdina, PD; Lapierre, YD; Ravindran, A | 1 |
| Domino, EF; Holmes, RD; Lee, A; Markel, H | 1 |
| Bakish, D; Cavazzoni, P; Chudzik, J; Hrdina, PD; Ravindran, A | 1 |
| Allard, P; Mjörndal, T; Spigset, O | 1 |
| Aberg-Wistedt, A; Kjellman, BF; Stain-Malmgren, R | 1 |
| Adolfsson, R; Allard, P; Mjörndal, T; Smedh, K; Spigset, O | 1 |
| Allard, P; Hägglöf, B; Mjörndal, T; Sigurdh, J; Spigset, O | 1 |
| Aberg-Wistedt, A; Khoury, AE; Stain-Malmgren, R; Tham, A | 1 |
| Allard, P; Bäckström, T; Bixo, M; Mjörndal, T; Nyberg, S; Spigset, O; Sundström-Poromaa, I | 1 |
| Allard, P; Bäckström, T; Mjörndal, T; Spigset, O; Sundström-Poromaa, I; Wihlbäck, AC | 1 |
| Aberg-Wistedt, A; El Khoury, A; Johnson, L; Stain-Malmgren, R | 1 |
| Callebert, J; Chabane, N; Delorme, R; Falissard, B; Launay, JM; Leboyer, M; Mouren-Siméoni, MC; Rouillon, F | 1 |
| Allard, P; Bixo, M; Mjörndal, T; Spigset, O; Sundström Poromaa, I; Wihlbäck, AC | 1 |
| Betancur, C; Callebert, J; Chabane, N; Delorme, R; Laplanche, JL; Launay, JM; Leboyer, M; Mouren-Simeoni, MC | 1 |
| Coccaro, EF; Lee, R; Marseille, R | 1 |
8 trial(s) available for paroxetine and lysergic acid diethylamide
| Article | Year |
|---|---|
Platelet binding characteristics distinguish placebo responders from nonresponders in depression.
Topics: Adult; Biomarkers; Blood Platelets; Depressive Disorder; Female; Humans; Iodine Radioisotopes; Lysergic Acid Diethylamide; Male; Paroxetine; Placebos; Psychiatric Status Rating Scales; Receptors, Serotonin; Regression Analysis | 1995 |
Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
Topics: Adolescent; Adult; Biomarkers; Blood Platelets; Depressive Disorder; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Paroxetine; Radioligand Assay; Receptors, Serotonin; Sex Factors; Up-Regulation | 1995 |
Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.
Topics: Adult; Blood Platelets; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Paroxetine; Personality Inventory; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin | 1997 |
Serotonergic function in major depression and effect of sertraline and paroxetine treatment.
Topics: Administration, Oral; Adult; Depressive Disorder; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sertraline; Treatment Outcome | 2001 |
Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
Topics: Adult; Blood Platelets; Buserelin; Cross-Over Studies; Double-Blind Method; Female; Follicular Phase; Humans; Luteal Phase; Lysergic Acid Diethylamide; Paroxetine; Placebos; Premenstrual Syndrome; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Tritium | 2001 |
Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin 2A receptor binding.
Topics: Blood Platelets; Carrier Proteins; Cross-Over Studies; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lysergic Acid Diethylamide; Medroxyprogesterone Acetate; Middle Aged; Paroxetine; Premenstrual Syndrome; Progesterone Congeners; Radioligand Assay; Receptors, Serotonin | 2001 |
Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
Topics: Adolescent; Adult; Binding Sites; Biomarkers; Blood Platelets; Carrier Proteins; Cell Membrane; Child; Diet; Female; France; Humans; Imipramine; Inositol Phosphates; Iodine Isotopes; Lysergic Acid Diethylamide; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Radiochemistry; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome; Tritium; Tryptophan | 2004 |
Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding.
Topics: Adult; Blood Platelets; Carrier Proteins; Estradiol; Female; Humans; Lysergic Acid Diethylamide; Menstrual Cycle; Paroxetine; Progesterone; Receptor, Serotonin, 5-HT2A; Reference Values; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists | 2004 |
11 other study(ies) available for paroxetine and lysergic acid diethylamide
| Article | Year |
|---|---|
Serotonergic aspects of the response of human platelets to immune-adjuvant muramyl dipeptide.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adenosine Diphosphate; Adjuvants, Immunologic; Blood Platelets; Carrier Proteins; Humans; Imipramine; Ketanserin; Lysergic Acid Diethylamide; Paroxetine; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1992 |
Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amphetamine (MDA).
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Behavior, Animal; Catecholamines; Cerebral Cortex; Hippocampus; Indans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Piperidines; Psychotropic Drugs; Rats; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1990 |
Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
Topics: 5-Methoxytryptamine; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Citalopram; Electric Stimulation; Fenclonine; Hypothalamus; Imipramine; Lysergic Acid Diethylamide; Male; Methiothepin; Neurotransmitter Agents; Pargyline; Paroxetine; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1985 |
LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Depressive Disorder; Drug Interactions; Female; Humans; Lysergic Acid Diethylamide; Male; Paroxetine; Recurrence; Sertraline; Substance-Related Disorders; Syndrome | 1994 |
Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
Topics: Adult; Blood Platelets; Carrier Proteins; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Paroxetine; Periodicity; Receptor, Serotonin, 5-HT2A; Receptors, Drug; Receptors, Serotonin; Reference Values; Seasons | 1998 |
Platelet serotonergic functions and light therapy in seasonal affective disorder.
Topics: Adult; Aged; Blood Platelets; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Paroxetine; Phototherapy; Receptors, Serotonin; Seasonal Affective Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin | 1998 |
Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy.
Topics: Adult; Aged; Blood Platelets; Case-Control Studies; Female; Humans; Longitudinal Studies; Lysergic Acid Diethylamide; Male; Middle Aged; Paroxetine; Phototherapy; Regression Analysis; Seasonal Affective Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents | 1999 |
Binding of [(3)H]lysergic acid diethylamide to serotonin 5-HT(2A) receptors and of [(3)H]paroxetine to serotonin uptake sites in platelets from healthy children, adolescents and adults.
Topics: Adolescent; Adult; Aging; Binding Sites; Blood Platelets; Child; Female; Humans; Lysergic Acid Diethylamide; Male; Paroxetine; Receptors, Serotonin; Reference Values; Selective Serotonin Reuptake Inhibitors; Serotonin Agents | 1999 |
Effects of long-term lithium treatment on monoaminergic functions in major depression.
Topics: Adult; Aged; Bipolar Disorder; Blood Platelets; Carrier Proteins; Depressive Disorder, Major; Female; Humans; Lithium Carbonate; Lysergic Acid Diethylamide; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Radioligand Assay; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome | 2001 |
Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Biomarkers; Blood Platelets; Case-Control Studies; Child; Female; Genotype; Humans; Imipramine; Inositol 1,4,5-Trisphosphate; Iodine Isotopes; Lysergic Acid Diethylamide; Male; Middle Aged; Minisatellite Repeats; Obsessive-Compulsive Disorder; Paroxetine; Radioimmunoassay; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Statistics as Topic; Statistics, Nonparametric; Tritium | 2005 |
Inter-relationship between different platelet measures of 5-HT and their relationship to aggression in human subjects.
Topics: Adult; Aggression; Blood Platelets; Humans; Impulsive Behavior; Iodine Radioisotopes; Lysergic Acid Diethylamide; Male; Paroxetine; Personality Disorders; Psychiatric Status Rating Scales; Radioligand Assay; Radionuclide Imaging; Receptors, Serotonin, 5-HT2; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tritium | 2012 |